About Journal

Oncology and Immunotherapy Association is a partner to EJMI

Aims and Scope
The Eurasian Journal of Medical Investigation is an open access journal.
All articles is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC)
Aim of the journal is to publish qualified research material on its scope. The target readership includes academic members or specialists on medicine. Scope of the journal covers medicine.
Eurasian Journal of Medical Investigation ( EJMI ) publishes articles following a double-blind peer review mechanism to ensure the standards of its publications.

Basic Publication Rules
Authors are responsible for the accuracy of data and the journal is in compliance with the uniform requirements for manuscripts submitted to biomedical journals published by the ICMJE. The editorial and publication processes of the journal are conducted in accordance with the guidelines of the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the European Association of Science Editors (EASE), and the Committee on Publication Ethics (COPE) as well.

Disclaimer
Statements or opinions expressed in the manuscripts published in Eurasian Journal of Medical Investigation reflect the views of the author(s) and not the opinions of the editors, the editorial board and the publisher; the editors, the editorial board and the publisher disclaim any responsibility or liability for such materials.

Abstracting and Indexing
EJMI is being evaluated by EBSCOhost, SCOPUS, ESCI
EJMI has been indexed in TUBITAK TR Index since 2019
TUBITAK is an institution of Republic Of Turkey Ministry of Industry and Technology
EJMI has been indexed in Index Copernicus Journal Master List since 2017
EJMI has been indexed in ProQuest Since 2020

Abbreviation
ejmi

Publication Fees

( For author from Turkey) There is no fee for article processing, submission or publication

( For Authors From Other Countries )
Fee Waiver Policy:Yes, Waives are considered.
Research Articles: $ 300
Case reports : $ 150
Review articles: $ 300

Revenue sources
Supported by other journal ejmo.org
Access to Journal Content
The abstracts and full texts of published articles can be accessed free of charge at www.ejmi.org www.ejmi.org
Digital archiving and preservation policy
If journal stops publishing : We intend and expect to continue to publish our journal for a very long time. If, due to some rare, unfortunate circumstances, we are forced to stop publishing the journal, the manuscripts published in the journal will be kept online and accessible to the readers through TUBITAK (TUBITAK is an institution of Republic Of Turkey Ministry of Industry and Technology) and Turkish Medline National Health Sciences Periodicals Database http://www.turkmedline.net/ and ULAKBIM

Editor

Hilmi Kodaz, MD.
Acibadem Eskisehir Hospital, Department of Oncology; Eskisehir-Turkey
E-mail: hilmikodaz@hotmail.com and admin@ejmi.org

Owner-Contact

Hilmi Kodaz, MD.
Acibadem Eskisehir Hospital, Department of Oncology; Eskisehir-Turkey
Address: Batikent Mah., Baglarbasi Sk., Starlife sitesi. 13 F No: 1, Tepebasi, Eskisehir-Turkey
Phone: +90 507 931 42 86
E-mail: hilmikodaz@hotmail.com and admin@ejmi.org

Publisher

Oncology and Immunotherapy Association is a partner to EJMI

Kare Publishing
Address: Concord Istanbul, Dumlupinar Mah. Cihan Sk. No: 15 B Blok Da: 162, 34720 Kadikoy, Istanbul-Turkey
Phone: +90 216 550 61 11
Fax: +90 216 550 61 12
Web : www.kareyayincilik.com
E-mail: kare@kareyayincilik.com